Key facts
- BAIBYS Fertility’s last known valuation is $10.0M (Dec 2026).
- It has raised $6.4M; the latest was Later Stage VC ($10.0M) in Dec 2026.
- Notable investors include MassChallenge, Nvidia, Innovation Authority, CVX Ventures, Aescuvest — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for BAIBYS Fertility
- ·The full record, as it builds
Funding rounds
No funding rounds for BAIBYS Fertility are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BAIBYS Fertility
Developer of an AI (artificial intelligence)-powered autonomous robotic platform intended to standardize and automate sperm selection and isolation in IVF (In Vitro Fertilization) procedures. The company offers a cartridge-based workflow with automated sample scanning, morphology and motility evaluation, and robotic cell isolation, enabling fertility clinics to improve consistency, efficiency, and clinical outcomes.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2000
- Employees
- 8
- Website
- baibys.com/
- Ownership
- Privately Held (backing)
BAIBYS Fertility doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BAIBYS Fertility shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BAIBYS Fertility in its N-PORT filings yet. We sweep new filings monthly.